IndraLab

Statements

EC 3.5.1.98 (histone deacetylase) inhibitor activates KCNH2. 2 / 2

| 1 1

sparser

"According to our data, caution must nonetheless be taken when using these pleiotropic agents with widespread effects, as in addition to derepressing TSGs silenced in cancer, HDACi could activate and promote HERG1 and hEAG1 oncogenic potential."

26785772

➶

reach

"According to our data, caution must nonetheless be taken when using these pleiotropic agents with widespread effects, as in addition to derepressing TSGs silenced in cancer, HDACi could activate and promote HERG1 and hEAG1 oncogenic potential."

26785772

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

EC 3.5.1.98 (histone deacetylase) inhibitor activates KCNH2. 2 / 2

INDRA sources:

Databases

Reading